By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kinex Pharmaceuticals 

1207 Delaware Avenue

Buffalo  New York  14209  U.S.A.
Phone: 716-332-6107 Fax: 716-332-6170


SEARCH JOBS








Company News
Kinex Pharmaceuticals Announces Allowance Of The Investigational New Drug (IND) Application For KX2-391 Ointment By The United States FDA 7/24/2014 11:04:31 AM
Kinex Pharmaceuticals Appoints Mr. Michael Murphy To The Board Of Directors 7/1/2014 11:50:30 AM
Hanmi Pharmaceutical, Co., Ltd And Collaborative Partner Kinex Pharmaceuticals Report Encouraging Results On Oraxol® For Patients With Advanced Gastric Cancer From A Phase I/II Clinical Study 6/30/2014 9:05:33 AM
Kinex Pharmaceuticals Announces Key Additions To Clinical Leadership Team In Newly Formed Clinical Development Office In Cranford, New Jersey 5/13/2014 9:40:40 AM
Kinex Pharmaceuticals Receives FDA Allowance For Oratecan, An Oral Form Of Irinotecan With Enhanced Gastrointestinal Absorption, The Second U.S. IND Based On The Orascovery Technology Platform 5/5/2014 8:52:50 AM
Kinex Pharmaceuticals And Zenith Technology To Initiate Clinical Studies Of An Oral Form Of Paclitaxel (Oraxol) In New Zealand 3/20/2014 10:32:47 AM
Kinex Pharmaceuticals Completes Oversubscribed $40 Million Private Placement Equity Raise 3/5/2014 6:07:59 AM
Kinex Pharmaceuticals And PharmaEssentia Expand Drug Development Partnership 2/6/2014 9:58:50 AM
Kinex Pharmaceuticals Appoints Executives To Clinical Leadership Team 2/5/2014 9:01:59 AM
Kinex Pharmaceuticals Announced That The FDA Has Granted Orphan Drug Status To KX02 For The Treatment Of Gliomas 12/4/2013 11:03:20 AM
12345
//-->